[Use of glucagon by continuous perfusion in the treatment of shock states].
D000328:Adult; D000818:Animals; D002415:Cats; D004285:Dogs; D004357:Drug Synergism; D005260:Female; D005934:Glucagon / Q000008:administration & dosage* / Q000494:pharmacology; D006321:Heart / Q000187:drug effects; D006329:Heart Conduction System / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007275:Injections, Intravenous; D007545:Isoproterenol / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011817:Rabbits; D012769:Shock / Q000188:drug therapy*; D012772:Shock, Septic / Q000188:drug therapy; D012774:Shock, Traumatic / Q000188:drug therapy
D005934:Glucagon; D007545:Isoproterenol
Utilisation du glucagon en perfusion continue dans le traitement des états de choc.